Through a targeted funding opportunity, the CTSI’s Office of Discovery and Translation has selected four UMN projects to receive funding and guidance. Congratulations to the awardees!
Nearly 80 technology innovators, clinicians, investors, academics and members of the medical device industry gathered in April to better understand academic-industry relationship barriers and catalysts for innovation during the fifth annual Pediatric Device Breakthrough Collaborative event.
A project that was initially funded through the Pediatric Device Innovation Consortium’s Community Discovery Program for Child Health Innovation, which is managed by CTSI’s Office of Discovery and Translation, was featured in the Business section of the Sunday, March 31 Star Tribune.
A new CTSI funding opportunity is available for University of Minnesota researchers to support the development of innovations that address challenges faced by family and unpaid/informal caregivers.
A sixth cycle of funding is available through a collaboration between CTSI and the Mayo Clinic's Center for Clinical and Translational Science, and in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics for projects that have the potential to be commercialized through the formation of a start-up company or execution of a license agreement with an established commercial entity.
Three research projects have been selected to each receive $50,000 in initial project funding and support through CTSI's Translational Product Development Fund (TPDF) to advance along the translational development pathway toward the formation of a start-up company or execution of a license agreement.
The fourth annual Pediatric Device Breakthrough Collaborative event, hosted by the Pediatric Device Innovation Consortium (PDIC), supported by CTSI, and held in conjunction with the Design of Medical Devices conference, recently attracted 60 medical device industry representatives, innovators, clinicians, and investors with a common goal of improving pediatric health and medical technology.
A new RFA is available through the Translational Product Development Fund for projects that have the potential to be commercialized through the formation of a start-up company or execution of a license agreement with an established commercial entity; apply by Feb. 7.
Two early-stage translational research project—focused on rare diseases—receive CTSI project support and funding to help determine critical path milestones, identify key gaps, and strengthen their likelihood to be developed into a new product or treatment approach.
Several areas across the University, including CTSI, recently came together to provide funding and project support for three University researchers and their microbiome analysis technology—to get it out of the lab and into the marketplace so that it can improve human health.
- Academic Health Center / Health Sciences (37)
- Accelerating discoveries (55)
- Advancing child health discoveries (26)
- Biomedical informatics (22)
- Biostatistical support (15)
- BLS (BioNet) (7)
- BMIP (25)
- BPIC (12)
- CEARCH (65)
- Clinical data repository (12)
- Clinical research professional (10)
- Clinical research services (45)
- Clinical trial management system / OnCore (10)
- Clinical trials (26)
- Community engagement in research (73)
- Community Engagement Studio (2)
- Community Research Institute (1)
- CTR Portal (5)
- CTRS (34)
- CTSA consortium (17)
- CTSI event (32)
- CTSI-Ed (89)
- Early-stage research (39)
- Fairview Research Administration (11)
- Grant (81)
- i2b2 (5)
- Interdisciplinary research (10)
- M Health (6)
- MARCH (1)
- Multisite research (14)
- NCATS (23)
- NIH (25)
- ODAT (46)
- Participate in a study (9)
- PCORI (3)
- Pilot funding (38)
- REDCap (6)
- Regulatory support (10)
- Research career & workforce development (90)
- Research mentor (43)
- Research participant recruitment (15)
- Research Toolkit (3)
- Research tools (38)
- ResearchMatch (2)
- RFA (29)
- Specimen procurement (6)
- StudyFinder (10)
- Team Science (39)
- University of Minnesota (162)